Phenomic AI Companies
Phenomic AI uses artificial intelligence to analyze phenotypes in complex disease models, including high-content co-culture and 3D assays, to discover and optimize therapeutics directly against phenotypic assays. The company's drug discovery platform makes it easier for pharmaceutical companies to discover drugs.
Investors
.png)
.png)
Funding Status:
Seed
Industry:
BioTech & Health Care
Estimated Revenue:
$6 million
Technology:
Artificial Intelligence, Biotechnology, Information Technology, Machine Learning
Headquarters:
Toronto, Ontario, Canada
Total Funding:
11391214.0
Last Funding Date:
2020-10-07
Last Funding Type:
Seed
Employee Number:
5
Investors Number:
13.0
Founded Date:
2017-01-01